Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

223.01 +4.03 (+1.84%)
Official Closing Price Updated: 4:10 PM EST, Dec 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,269,220
Open 219.03
Bid (Size) 219.60 (1)
Ask (Size) 224.00 (1)
Prev. Close 218.98
Today's Range 218.96 - 223.88
52wk Range 218.75 - 249.89
Shares Outstanding 287,190,180
Dividend Yield 1.70%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
13 Healthcare Sector Stocks With Healthy Valuation
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities

Performance

YTD
-9.13%
-9.13%
1 Month
-3.73%
-3.73%
3 Month
-5.99%
-5.99%
6 Month
-6.89%
-6.89%
1 Year
-4.45%
-4.45%

More News

Read More
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Via Benzinga
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
Via Benzinga
Price Over Earnings Overview: Becton Dickinson
Via Benzinga
A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
Via Benzinga
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
Via Benzinga
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
Via Benzinga
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Via Talk Markets
Top Analyst Reports For Nvidia, American Express & Wells Fargo
Via Talk Markets
Looking Into Becton Dickinson's Recent Short Interest
Via Benzinga
Key Takeaways From Becton Dickinson Analyst Ratings
Via Benzinga
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024
Via InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Via Benzinga
Looking Into Becton Dickinson's Recent Short Interest
Via Benzinga
3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends
Via InvestorPlace
Topics Retirement
Exposures Pension
Peering Into Becton Dickinson's Recent Short Interest
Via Benzinga
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
Via Benzinga
Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.
Via InvestorPlace
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
Via Benzinga
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Via Investor's Business Daily
Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs
Via InvestorPlace
Topics World Trade
Exposures Tariff
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.